Literature DB >> 32409499

Obesity Is a Risk Factor for Greater COVID-19 Severity.

Feng Gao1, Kenneth I Zheng2, Xiao-Bo Wang3, Qing-Feng Sun4, Ke-Hua Pan5, Ting-Yao Wang6, Yong-Ping Chen2, Giovanni Targher7, Christopher D Byrne8, Jacob George9, Ming-Hua Zheng10,11,12.   

Abstract

Entities:  

Year:  2020        PMID： 32409499     DOI： 10.2337/dc20-0682

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  117 in total

1.  The COVID-19 immune landscape is dynamically and reversibly correlated with disease severity.

Authors:  Hamid Bolouri; Cate Speake; David Skibinski; S Alice Long; Anne M Hocking; Daniel J Campbell; Jessica A Hamerman; Uma Malhotra; Jane H Buckner
Journal:  J Clin Invest       Date:  2021-02-01       Impact factor: 14.808

Review 2.  Global pandemics interconnected - obesity, impaired metabolic health and COVID-19.

Authors:  Norbert Stefan; Andreas L Birkenfeld; Matthias B Schulze
Journal:  Nat Rev Endocrinol       Date:  2021-01-21       Impact factor: 43.330

3.  High plasma concentration of non-esterified polyunsaturated fatty acids is a specific feature of severe COVID-19 pneumonia.

Authors:  Maxime Nguyen; Abderrahmane Bourredjem; Lionel Piroth; Bélaïd Bouhemad; Antoine Jalil; Gaetan Pallot; Naig Le Guern; Charles Thomas; Thomas Pilot; Victoria Bergas; Hélène Choubley; Jean-Pierre Quenot; Pierre-Emmanuel Charles; Laurent Lagrost; Valerie Deckert; Jean-Paul Pais de Barros; Pierre-Grégoire Guinot; David Masson; Christine Binquet; Thomas Gautier; Mathieu Blot
Journal:  Sci Rep       Date:  2021-05-24       Impact factor: 4.379

4.  Severe Acute Respiratory Syndrome Coronavirus-2 Infection in Children With Liver Transplant and Native Liver Disease: An International Observational Registry Study.

Authors:  Mohit Kehar; Noelle H Ebel; Vicky L Ng; Jairo Eduardo Rivera Baquero; Daniel H Leung; Voytek Slowik; Nadia Ovchinsky; Amit A Shah; Ronen Arnon; Tamir Miloh; Nitika Gupta; Saeed Mohammad; Debora Kogan-Liberman; James E Squires; Maria Camila Sanchez; Amber Hildreth; Linda Book; Christopher Chu; Leina Alrabadi; Ruba Azzam; Bhavika Chepuri; Scott Elisofon; Rachel Falik; Lisa Gallagher; Howard Kader; Douglas Mogul; Quais Mujawar; Shweta S Namjoshi; Pamela L Valentino; Bernadette Vitola; Nadia Waheed; Ming-Hua Zheng; Steven Lobritto; Mercedes Martinez
Journal:  J Pediatr Gastroenterol Nutr       Date:  2021-06-01       Impact factor: 2.839

Review 5.  JAK out of the Box; The Rationale behind Janus Kinase Inhibitors in the COVID-19 setting, and their potential in obese and diabetic populations.

Authors:  Rahma Menshawey; Esraa Menshawey; Ayman H K Alserr; Antoine Fakhry Abdelmassih
Journal:  Cardiovasc Endocrinol Metab       Date:  2020-10-15

6.  Obesity and mortality in critically ill COVID-19 patients with respiratory failure.

Authors:  Richard Dana; Aurélie Bannay; Pauline Bourst; Caroline Ziegler; Marie-Reine Losser; Sébastien Gibot; Bruno Levy; Gérard Audibert; Olivier Ziegler
Journal:  Int J Obes (Lond)       Date:  2021-06-10       Impact factor: 5.551

7.  Is Obesity a Potential Risk factor for Poor Prognosis of COVID-19?

Authors:  Meltem Agca; Eylem Tuncay; Elif Yıldırım; Reyhan Yıldız; Tülin Sevim; Dilek Ernam; Nermin Ozer Yılmaz; Nazlı Huma Teke; Simge Yavuz; Zuhal Karakurt; Ipek Ozmen
Journal:  Infect Chemother       Date:  2021-06

Review 8.  Obesity in people with diabetes in COVID-19 times: Important considerations and precautions to be taken.

Authors:  Adriano Alberti; Fabiana Schuelter-Trevisol; Betine Pinto Moehlecke Iser; Eliane Traebert; Viviane Freiberger; Leticia Ventura; Gislaine Tezza Rezin; Bruna Becker da Silva; Fabiana Meneghetti Dallacosta; Leoberto Grigollo; Paula Dias; Gracielle Fin; Josiane Aparecida De Jesus; Fabiane Pertille; Carina Rossoni; Ben Hur Soares; Rudy José Nodari Júnior; Clarissa Martinelli Comim
Journal:  World J Clin Cases       Date:  2021-07-16       Impact factor: 1.337

Review 9.  Cardiopulmonary Pathophysiological Aspects in the Context of COVID-19 and Obesity.

Authors:  Abdallah Fayssoil; Marie Charlotte De Carne De Carnavalet; Nicolas Mansencal; Frederic Lofaso; Benjamin Davido
Journal:  SN Compr Clin Med       Date:  2021-06-14

10.  Effect of IBD medications on COVID-19 outcomes: results from an international registry.

Authors:  Jean-Frederic Colombel; Michael D Kappelman; Ryan C Ungaro; Erica J Brenner; Richard B Gearry; Gilaad G Kaplan; Michele Kissous-Hunt; James D Lewis; Siew C Ng; Jean-Francois Rahier; Walter Reinisch; Flávio Steinwurz; Fox E Underwood; Xian Zhang
Journal:  Gut       Date:  2020-10-20       Impact factor: 31.793
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.